Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators.

BACKGROUND To distinguish prolonged episodes of atrial fibrillation (AF) that require cardioversion from self-terminating episodes that do not, an atrial implantable cardioverter-defibrillator (ICD) must be able to detect AF continuously for extended periods. The ICD should discriminate between atrial tachycardia/flutter (AT), which may be terminated by antitachycardia pacing, and AF, which requires cardioversion. METHODS AND RESULTS We studied 80 patients with AT/AF and ventricular arrhythmias who were treated with a new atrial/dual-chamber ICD. During a follow-up period lasting 6+/-2 months, we validated spontaneous, device-defined AT/AF episodes by stored electrograms in all patients. In 58 patients, we performed 80 Holter recordings with telemetered atrial electrograms, both to validate the continuous detection of AT/AF and to determine the sensitivity of the detection of AT/AF. Detection was appropriate in 98% of 132 AF episodes and 88% of 190 AT episodes (98% of 128 AT episodes with an atrial cycle length <300 ms). Intermittent sensing of far-field R waves during sinus tachycardia caused 27 inappropriate AT/AF detections; these detections lasted 2.6+/-2.0 minutes. AT/AF was detected continuously in 27 of 28 patients who had spontaneous episodes of AT/AF (96%). The device memory recorded 90 appropriate AT/AF episodes lasting >1 hour, for a total of 2697 hours of continuous detection of AT/AF. During Holter monitoring, the sensitivity of the detection of AT/AF (116 hours) was 100%; the specificity of the detection of non-AT/AF rhythms (1290 hours) was 99.99%. Of 166 appropriate episodes detected as AT, 45% were terminated by antitachycardia pacing. CONCLUSIONS A new ICD detects AT/AF accurately and continuously. Therapy may be programmed for long-duration AT/AF, with a low risk of underdetection. Discrimination of AT from AF permits successful pacing therapy for a significant fraction of AT.

[1]  A. Camm,et al.  Initial Clinical Experience with an Implantable Human Atrial Defibrillator , 1997, Pacing and clinical electrophysiology : PACE.

[2]  Clinical testing of a dual chamber atrial tachyarrhythmia detection algorithm , 1996, Computers in Cardiology 1996.

[3]  B Letac,et al.  Automatic arrhythmia identification using analysis of the atrioventricular association. Application to a new generation of implantable defibrillators. Participating Centers of the Automatic Recognition of Arrhythmia Study Group. , 1997, Circulation.

[4]  C. Bucknall,et al.  Is mode switching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias. , 1997, Journal of the American College of Cardiology.

[5]  J. Bonnet,et al.  Mode Switch Despite Undersensing of Atrial Fibrillation in ODD Pacing , 1996, Pacing and clinical electrophysiology : PACE.

[6]  B. Lüderitz,et al.  Electrical Proarrhythmia: Induction of Inappropriate Atrial Therapies due to Far‐Field R Wave Oversensing in a New Dual Chamber Defibrillator , 1998, Journal of cardiovascular electrophysiology.

[7]  J. Brouwer,et al.  Analysis of Atrial Sensed Far‐Field Ventricnlar Signals: A Reassessment , 1997, Pacing and clinical electrophysiology : PACE.

[9]  N. Kouchoukos,et al.  Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery * , 1978, Pacing and clinical electrophysiology : PACE.

[10]  An atrial fibrillation detection algorithm for an implantable atrial defibrillator , 1995, Computers in Cardiology 1995.

[11]  A J Camm,et al.  Atrioverter: an implantable device for the treatment of atrial fibrillation. , 1998, Circulation.